Watchlist Price Alert

Rocket Pharmaceuticals In... (RCKT)

NASDAQ: RCKT · Real-Time Price · USD

2.87

-0.01 (-0.35%)

At close: Jun 17, 2025, 10:45 AM

Rocket Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	7.1M	6.27M	5.37M	1.15M	426K	330K	204K	169K
Gross Profit	n/a	-7.1M	-6.27M	-5.37M	-1.15M	-426K	-330K	-204K	-169K
Operating Income	-273.2M	-259.66M	-224.34M	-167.25M	-134.3M	-76.15M	-71.16M	-26.74M	-41.88M
Interest Income	n/a	15.94M	3.89M	3.07M	2.15M	3.41M	1.69M	819K	443K
Pretax Income	-258.75M	-245.59M	-221.86M	-169.07M	-139.7M	-77.27M	-74.52M	-29.5M	-42.85M
Net Income	-258.75M	-245.59M	-219.38M	-169.59M	-146.67M	-83.23M	-74.52M	-29.5M	-42.85M
Selling & General & Admin	101.96M	73.32M	58.77M	41.77M	27.92M	17.53M	17.89M	12.54M	9.89M
Research & Development	171.24M	180.97M	165.57M	125.48M	106.38M	58.62M	53.27M	14.19M	31.98M
Other Expenses	n/a	n/a	-500K	-1M	n/a	-250K	186K	n/a	n/a
Operating Expenses	273.2M	259.66M	223.84M	166.25M	134.3M	75.9M	70.97M	26.74M	41.88M
Interest Expense	n/a	1.88M	1.91M	5.89M	7.55M	4.78M	5.24M	3.58M	1.42M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	259.66M	223.84M	166.25M	134.3M	75.9M	70.97M	26.74M	41.88M
Income Tax Expense	n/a	n/a	-2.48M	516K	6.97M	5.96M	2.68M	819K	443K
Shares Outstanding (Basic)	94.81M	84.01M	68.15M	63.24M	55.38M	49.01M	39.38M	6.77M	6.68M
Shares Outstanding (Diluted)	94.81M	84.01M	68.15M	63.24M	55.38M	49.01M	39.38M	6.77M	6.68M
EPS (Basic)	-2.73	-2.92	-3.22	-2.68	-2.65	-1.7	-1.89	-4.36	-6.41
EPS (Diluted)	-2.73	-2.92	-3.22	-2.68	-2.65	-1.7	-1.89	-4.36	-6.41
EBITDA	-273.2M	-236.62M	-213.69M	-161.72M	-131.59M	-71.14M	-71.16M	-26.74M	-41.27M
EBIT	-260.63M	-243.72M	-220.5M	-167.09M	-132.73M	-71.56M	-68.67M	-20.21M	-41.44M
Depreciation & Amortization	n/a	7.1M	6.27M	5.37M	1.15M	426K	330K	204K	169K